**Core Concept:** Flow cytometry is a diagnostic tool used to analyze the expression of various cell surface markers on leukocytes. In acute myeloid leukemia (AML), the classification system known as French-American-British (FAB) is used to categorize AML subtypes based on morphological, cytogenetic, and immunophenotypic characteristics.

**Why the Correct Answer is Right:** When performing flow cytometry on an AML patient, the detection of CD41 and CD61 positivity indicates the presence of myeloperoxidase (MPO) enzyme, which is a hallmark of myeloid lineage cells. The correct answer (C) refers to the M5 variant of AML, also known as acute megakaryoblastic leukemia (AML-M5). This variant is characterized by the predominance of megakaryocytic lineage cells and CD41 and CD61 positivity, alongside the absence of myeloblasts expressing myeloid lineage markers.

**Why Each Wrong Option is Incorrect:**

A. This option refers to the M4 variant of AML, also known as acute erythroleukemia (AML-M4). AML-M4 presents with erythroid lineage cells and lacks CD41 and CD61 positivity.

B. This option refers to the M3 variant of AML, also known as acute promyelocytic leukemia (APL). APL is characterized by the presence of PML-RARA fusion gene, not CD41 and CD61 positivity.

D. This option refers to the M2 variant of AML, also known as acute monoblastic leukemia (AML-M2). AML-M2 is characterized by the presence of monocytic lineage cells and lacks CD41 and CD61 positivity.

**Clinical Pearl:** Flow cytometry plays a crucial role in diagnosing and distinguishing various AML subtypes, as it allows for the identification of specific cell surface markers and lineage-specific antigens. In the case of AML, flow cytometry aids in identifying the predominance of myeloid or lymphoid lineage cells and helps in determining the appropriate treatment strategy and prognosis.